Close Menu
The Business TimesThe Business Times
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
What's On

August Income: 2 Raises From High Yield 5.7 – 8%

15 September 2026

ASE Technology Stock Can Miss August’s Run Rate And Still Beat Q3 Guidance (NYSE:ASX)

15 September 2026

Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

15 September 2026

Kobe Bussan Co., Ltd. 2026 Q3 – Results – Earnings Call Presentation (OTCMKTS:KOBCY) 2026-09-14

15 September 2026

CytomX Therapeutics, Inc. (CTMX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

14 September 2026
Facebook X (Twitter) Instagram
Business Tuesday, Sep 15
The Business TimesThe Business Times
Newsletter
  • Home
  • News
  • Business
  • Finance
  • Economy
  • Markets
  • Investing
  • Real Estate
  • Crypto
  • Fintech
  • Forex
  • More
    • Politics
    • Web Stories
    • Spotlight
    • Press Release
The Business TimesThe Business Times
Home » ASE Technology Stock Can Miss August’s Run Rate And Still Beat Q3 Guidance (NYSE:ASX)
News

ASE Technology Stock Can Miss August’s Run Rate And Still Beat Q3 Guidance (NYSE:ASX)

thebusinesstimes.co.ukBy thebusinesstimes.co.uk15 September 20260 Views
Facebook Twitter LinkedIn Reddit Telegram WhatsApp Pinterest Tumblr VKontakte Email
Share
Facebook Twitter LinkedIn Pinterest Email

This article was written by

Hey this is Sam, an independent investor with a degree in Finance from the University of Oklahoma. I have been investing my own money for several years, with a focus on finding companies that may be overlooked, misunderstood, or valued too conservatively by the market.I am most interested in small and mid sized companies with strong growth potential, especially within technology, artificial intelligence, financial technology, aerospace, and digital infrastructure. I am drawn to businesses operating in growing markets. I also look outside these areas when I find a company with a compelling valuation or an overlooked catalyst.My investing approach combines fundamental research with valuation, market sentiment, and technical analysis. I review financial statements, earnings reports, investor presentations, management commentary, industry trends, and competitive positioning before forming a thesis. I pay particular attention to revenue growth, margins, balance sheet strength, dilution risk, and whether current expectations already appear reflected in the share price.I write independently and am not affiliated with an investment firm. I joined Seeking Alpha to share research on companies that I believe deserve a closer look. My goal is to present a clear investment case, explain what could drive the stock higher, and address the risks that could prove the thesis wrong.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email Reddit Telegram WhatsApp

Related Articles

August Income: 2 Raises From High Yield 5.7 – 8%

Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Kobe Bussan Co., Ltd. 2026 Q3 – Results – Earnings Call Presentation (OTCMKTS:KOBCY) 2026-09-14

CytomX Therapeutics, Inc. (CTMX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Equifax Inc. (EFX) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Cellectis S.A. (CLLS) Discusses Strategic Transformation and In Vivo Gene Editing Pipeline Update Transcript

Northern Trust Corporation (NTRS) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

Galderma: Launch Investment Is Becoming An Earnings Engine (OTCMKTS:GALDY)

Editors Picks

ASE Technology Stock Can Miss August’s Run Rate And Still Beat Q3 Guidance (NYSE:ASX)

15 September 2026

Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

15 September 2026

Kobe Bussan Co., Ltd. 2026 Q3 – Results – Earnings Call Presentation (OTCMKTS:KOBCY) 2026-09-14

15 September 2026

CytomX Therapeutics, Inc. (CTMX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

14 September 2026

Subscribe to News

Get the latest finance and business news and updates directly to your inbox.

Latest Posts

Equifax Inc. (EFX) Presents at Barclays 24th Annual Global Financial Services Conference Transcript

14 September 2026

Moderna, Inc. (MRNA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

14 September 2026

Cellectis S.A. (CLLS) Discusses Strategic Transformation and In Vivo Gene Editing Pipeline Update Transcript

14 September 2026
Facebook X (Twitter) Pinterest WhatsApp TikTok Instagram
© 2026 The Business Times. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.